Abstract
Introduction A joint memorandum circular (JMC No. 2021-001) was released by the Commission on Higher Education (CHED) and the Department of Health (DOH) in the Philippines, outlining the guidelines on the gradual reopening of higher education campuses for limited face-to-face classes during the COVID-19 pandemic. Besides the strict enforcement of health protocols, the said circular recommended for the reduction of COVID-19 reproduction number by limiting the number of students present within the campus through the adoption of a cyclical student shifting model. This study evaluates 32 cyclical 2-shift models and how these schedules minimizes COVID-19 incidence in the campus.
Method A compartmental SEIRS model is used to simulate the number of infection for a 36-week period where the proposed 32 cyclical schedules and health protocols, such as the wearing of minimum personal protective gears and physical distancing, are inserted into the model.
Result The simulation has shown that all of the proposed schedules result to low disease transmission as long as there is strong adherence to health protocols among students or strict implementation of health policies for at least 18 weeks; otherwise, the 4-10 cycle model is recommended, or shifting schedules with 3-4 consecutive weeks of in-campus classes when health protocols are poorly implemented.
Conclusion The results of this study will guide university administrators in crafting their COVID-19 academic plan, especially in the selection of a suitable cyclical shifting schedule for their institution.
- face-to-face classes
- COVID-19
- health protocols
- public health
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the URDC of the West Visayas State University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
